LAQV/REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.
Research Institute for Medicines (iMed.Lisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal,
Molecules. 2018 Dec 10;23(12):3263. doi: 10.3390/molecules23123263.
A recurrent problem faced by the pharmaceutical industry when formulating drug products concerns poorly soluble drugs, which, despite having desirable pharmacological activity, present limited bioavailability. Cocrystallization is growing up as a possible approach to tackle this problem. Cocrystals are crystalline materials comprising at least two components, solid at room temperature, and held together by non-covalent bonds. The increasing interest in these compounds is steadily demanding faster, simpler, and more reliable methods for the task of screening new cocrystals. This work aims at comparing the performance of three vibrational spectroscopy techniques (mid infrared, near infrared, and Raman spectroscopy) for cocrystals screening. Presented results are based on hydrochlorothiazide, a poorly soluble drug belonging to class IV of the Biopharmaceutical Classification System. The implemented cocrystal screening procedure tested six coformers (all considered safe for human administration) added according to a drug:coformer ratio of 1:1 and 1:2 and seven solvents with different polarity. The screening method chosen was based on slurry cocrystallization performed by sonication (ultrasound assisted) in a 96-well plate. Results show that all evaluated vibrational spectroscopy techniques provided important information regarding cocrystal formation, including information on the groups involved in the cocrystallization and purity, and can be used for the screening task.
制药行业在制剂药物时面临的一个反复出现的问题是涉及难溶性药物,尽管这些药物具有理想的药理学活性,但生物利用度有限。共晶化作为解决这个问题的一种可能方法正在兴起。共晶是由至少两种成分组成的结晶材料,在室温下为固态,并通过非共价键结合在一起。人们对这些化合物的兴趣日益浓厚,这就要求更快、更简单、更可靠的方法来筛选新的共晶。本工作旨在比较三种振动光谱技术(中红外、近红外和拉曼光谱)在共晶筛选中的性能。所呈现的结果基于氢氯噻嗪,一种属于生物制药分类系统第四类的难溶性药物。所实施的共晶筛选程序测试了六种共晶形成剂(均被认为对人体给药安全),按照药物:共晶形成剂 1:1 和 1:2 的比例添加,并使用了七种具有不同极性的溶剂。所选择的筛选方法基于在 96 孔板中通过超声(超声波辅助)进行的悬浮共结晶。结果表明,所有评估的振动光谱技术都提供了关于共晶形成的重要信息,包括涉及共晶化的基团和纯度的信息,并且可用于筛选任务。